Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

FOV-2304 prevents retinal edema and inflammation in rat model of diabetic retinopathy

Dec. 18, 2009

Vorinostat in combination with tamoxifen safe and effective in phase II breast cancer trial

Dec. 17, 2009

Pilot trial data indicate beneficial effects of Copaxone in dry AMD

Dec. 17, 2009

Clinical data on candesartan in diabetic retinopathy disclosed at ISOPT

Dec. 17, 2009

Preliminary phase I safety and efficacy of IMGN-901 seen in pretreated MM patients

Dec. 17, 2009

Romiplostim safe and effective in phase I/II study in pediatric ITP patients

Dec. 17, 2009

Final data reported from phase Ib trial of atacicept in pretreated CLL patients

Dec. 17, 2009

Beneficial effects of SUN-11031 in COPD patients with cachexia reported

Dec. 16, 2009

Studies find benefit with intravitreal dexamethasone implant in ocular indications

Dec. 16, 2009

Pharmacyclics presents phase I data on lymphoma agents

Dec. 16, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...